Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement
Thursday, February 19, 2026Sensei Biotherapeutics Inc today announced that it has acquired Faeth Therapeutics Inc Faeth a clinicalstage biotechnology company developing multinode therapies that target tumor metabolism and signaling
Essential Pharma strengthens rare disease portfolio with acquisition of Ventavis® (iloprost trometamol) for adult primary pulmonary hypertension
Wednesday, February 18, 2026Essential Pharma a global specialty pharmaceutical company today announces the acquisition of Ventavis iloprost trometamol from Bayer AG including rights to the accompanying Breelib nebuliser delivery technology
Roche announces positive phase III results for Gazyva/Gazyvaro in primary membranous nephropathy, marking a significant milestone in this autoimmune disease
Tuesday, February 17, 2026Roche announced today that the phase III MAJESTY study in adults with primary membranous nephropathy met its primary endpoint showing statistically significant and clinically meaningful results with GazyvaGazyvaro
CStone Announces FDA Clearance of IND Application for Its Novel Trispecific Antibody CS2009 (PD-1/VEGF/CTLA-4) to Advance into Phase II Clinical Trial
Tuesday, February 17, 2026CStone Pharmaceuticals an innovationdriven biopharmaceutical company focused on the research and development of therapies for oncology autoimmuneinflammation and other key disease areas today announced that the US FDA has cleared the IND application
Aspire Pharma Strengthens European Footprint with Caragen Acquisition
Thursday, February 12, 2026Aspire Pharma Limited one of the UKs fastestgrowing specialty generics pharmaceutical businesses has acquired Caragen a Dublin based pharmaceutical organisation with a strong presence in hospital immunology therapies
Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases
Thursday, February 12, 2026Evogene Ltd a pioneering computational chemistry company specializing in the generative design of small molecules for the pharmaceutical and agricultural industries Systasy Bioscience GmbH a biotechnology company
Sanofi completes the acquisition of Dynavax
Wednesday, February 11, 2026Sanofi today announced that it has completed theacquisition of Dynavax Technologies Corporation Dynavax The acquisition includes Dynavaxs adult hepatitis B vaccine HEPLISAVB which is currently marketed in the US
Memo Therapeutics AG Enters into a Collaboration and Option Agreement with CSL for Development of Recombinant Polyclonal IgG Technology
Tuesday, February 10, 2026Memo Therapeutics AG MTx a latestage biotech company translating unique immune responses into superior medicines to treat viral infections and cancer today announced it has entered into a strategic collaboration and exclusive
Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC
Tuesday, February 10, 2026Bruker Corporation today announced the launch of iNTApharma a labelfree characterization platform that provides singleparticle sensitivity for the quantitative analysis of nanoscale bioparticles in native aqueous media
17th Edition Strategic Alliance Management for Pharma
Tuesday, February 10, 2026The pharmaceutical industry is a highly regulated and researchintensive sector dedicated to discovering developing manufacturing and marketing drugs that improve human and animal health
